152 related articles for article (PubMed ID: 12807883)
21. Solution properties of the free and DNA-bound Runt domain of AML1.
Wolf-Watz M; Xie XQ; Holm M; Grundström T; Härd T
Eur J Biochem; 1999 Apr; 261(1):251-60. PubMed ID: 10103057
[TBL] [Abstract][Full Text] [Related]
22. PEBP2/CBF, the murine homolog of the human myeloid AML1 and PEBP2 beta/CBF beta proto-oncoproteins, regulates the murine myeloperoxidase and neutrophil elastase genes in immature myeloid cells.
Nuchprayoon I; Meyers S; Scott LM; Suzow J; Hiebert S; Friedman AD
Mol Cell Biol; 1994 Aug; 14(8):5558-68. PubMed ID: 8035830
[TBL] [Abstract][Full Text] [Related]
23. A simple screening for mutant DNA binding proteins: application to murine transcription factor PEBP2alpha subunit, a founding member of the Runt domain protein family.
Akamatsu Y; Tsukumo S; Kagoshima H; Tsurushita N; Shigesada K
Gene; 1997 Jan; 185(1):111-7. PubMed ID: 9034321
[TBL] [Abstract][Full Text] [Related]
24. Core binding factor genes and human leukemia.
Hart SM; Foroni L
Haematologica; 2002 Dec; 87(12):1307-23. PubMed ID: 12495904
[TBL] [Abstract][Full Text] [Related]
25. Molecular basis for a dominant inactivation of RUNX1/AML1 by the leukemogenic inversion 16 chimera.
Huang G; Shigesada K; Wee HJ; Liu PP; Osato M; Ito Y
Blood; 2004 Apr; 103(8):3200-7. PubMed ID: 15070703
[TBL] [Abstract][Full Text] [Related]
26. Core-binding factors in hematopoiesis and immune function.
de Bruijn MF; Speck NA
Oncogene; 2004 May; 23(24):4238-48. PubMed ID: 15156179
[TBL] [Abstract][Full Text] [Related]
27. Altered affinity of CBF beta-SMMHC for Runx1 explains its role in leukemogenesis.
Lukasik SM; Zhang L; Corpora T; Tomanicek S; Li Y; Kundu M; Hartman K; Liu PP; Laue TM; Biltonen RL; Speck NA; Bushweller JH
Nat Struct Biol; 2002 Sep; 9(9):674-9. PubMed ID: 12172539
[TBL] [Abstract][Full Text] [Related]
28. Overexpression of core-binding factor alpha (CBF alpha) reverses cellular transformation by the CBF beta-smooth muscle myosin heavy chain chimeric oncoprotein.
Hajra A; Liu PP; Speck NA; Collins FS
Mol Cell Biol; 1995 Sep; 15(9):4980-9. PubMed ID: 7651416
[TBL] [Abstract][Full Text] [Related]
29. Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin-proteasome-mediated degradation.
Huang G; Shigesada K; Ito K; Wee HJ; Yokomizo T; Ito Y
EMBO J; 2001 Feb; 20(4):723-33. PubMed ID: 11179217
[TBL] [Abstract][Full Text] [Related]
30. Frequent downregulation of the runt domain transcription factors RUNX1, RUNX3 and their cofactor CBFB in gastric cancer.
Sakakura C; Hagiwara A; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ito K; Yamagishi H; Yazumi S; Chiba T; Ito Y
Int J Cancer; 2005 Jan; 113(2):221-8. PubMed ID: 15386419
[TBL] [Abstract][Full Text] [Related]
31. Redox regulation of the DNA binding activity in transcription factor PEBP2. The roles of two conserved cysteine residues.
Akamatsu Y; Ohno T; Hirota K; Kagoshima H; Yodoi J; Shigesada K
J Biol Chem; 1997 Jun; 272(23):14497-500. PubMed ID: 9169404
[TBL] [Abstract][Full Text] [Related]
32. Transcriptional activity of core binding factor-alpha (AML1) and beta subunits on murine leukemia virus enhancer cores.
Zaiman AL; Lewis AF; Crute BE; Speck NA; Lenz J
J Virol; 1995 May; 69(5):2898-906. PubMed ID: 7707514
[TBL] [Abstract][Full Text] [Related]
33. Chloride binding by the AML1/Runx1 transcription factor studied by NMR.
Wolf-Watz M; Bäckström S; Grundström T; Sauer U; Härd T
FEBS Lett; 2001 Jan; 488(1-2):81-4. PubMed ID: 11163800
[TBL] [Abstract][Full Text] [Related]
34. Functional domains of the t(8;21) fusion protein, AML-1/ETO.
Lenny N; Meyers S; Hiebert SW
Oncogene; 1995 Nov; 11(9):1761-9. PubMed ID: 7478604
[TBL] [Abstract][Full Text] [Related]
35. Crystallization and preliminary studies of the DNA-binding runt domain of AML1.
Bäckström S; Huang SH; Wolf-Watz M; Xie XQ; Härd T; Grundström T; Sauer UH
Acta Crystallogr D Biol Crystallogr; 2001 Feb; 57(Pt 2):269-71. PubMed ID: 11173476
[TBL] [Abstract][Full Text] [Related]
36. CBF--a biophysical perspective.
Bushweller JH
Semin Cell Dev Biol; 2000 Oct; 11(5):377-82. PubMed ID: 11105902
[TBL] [Abstract][Full Text] [Related]
37. RUNX transcription factors as key targets of TGF-beta superfamily signaling.
Ito Y; Miyazono K
Curr Opin Genet Dev; 2003 Feb; 13(1):43-7. PubMed ID: 12573434
[TBL] [Abstract][Full Text] [Related]
38. An enigmatic fourth runt domain gene in the fugu genome: ancestral gene loss versus accelerated evolution.
Glusman G; Kaur A; Hood L; Rowen L
BMC Evol Biol; 2004 Nov; 4():43. PubMed ID: 15527507
[TBL] [Abstract][Full Text] [Related]
39. Cytoplasmic sequestration of the polyomavirus enhancer binding protein 2 (PEBP2)/core binding factor alpha (CBFalpha) subunit by the leukemia-related PEBP2/CBFbeta-SMMHC fusion protein inhibits PEBP2/CBF-mediated transactivation.
Kanno Y; Kanno T; Sakakura C; Bae SC; Ito Y
Mol Cell Biol; 1998 Jul; 18(7):4252-61. PubMed ID: 9632809
[TBL] [Abstract][Full Text] [Related]
40. The cleidocranial dysplasia-related R131G mutation in the Runt-related transcription factor RUNX2 disrupts binding to DNA but not CBF-beta.
Han MS; Kim HJ; Wee HJ; Lim KE; Park NR; Bae SC; van Wijnen AJ; Stein JL; Lian JB; Stein GS; Choi JY
J Cell Biochem; 2010 May; 110(1):97-103. PubMed ID: 20225274
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
